How to Start/Build a Medical Device Company in These Tough Economic Times
Friday, April 24, 2009 from 8:00 AM to 4:00 PM (MDT)
Salt Lake City, United States
The Utah Fund of Funds Presents
How to Start and/or Build a Medical Device Company
in these Difficult Economic Times
Featuring World Class Professionals and Experts in developing Medical Device Companies
Featuring World Class Professionals and Experts
in developing Medical Device Companies
Mr. Mark Foley Managing- Director RWI Ventures
Dr. Peter J. Fitzgerald- Stanford Professor, Co-Founder of CRCI, Co-founder of Latterell Venture Partners
Dr. Randall Olson- CEO John A. Moran Center
Mr. Richard J. Linder- President and CEO Coherex Medical
Mr. Kelly Christian- Product Development Director Bard Medical
April 24, 2009 8:00 AM-4:00 pm at The Depot
(West of the Energy Solutions Arena and North of the Gateway)
8:00-8:45 Registration and check in
8:45-9:00 Introduction and Welcome Mr. Jeremy Neilson
9:00- 10:00 Building a Medical Device Company Mr. Mark Foley
10:00- 10:45 Local Story Mr. Richard Linder
11:00-12:00 Attracting Capital for Device Companies Dr. Peter J. Fitzgerald
12:00-1:00 Lunch (catered by Cuisine Unlimited)
1:00-1:30 Physician area of interest Dr. Randall Olson
1:30- 3:00 Panel Discussion:
Dr. Peter Fitzgerald, Mr. Mark Foley, Dr. Randall Olson, Mr. Richard Linder, Mr. Kelly Christian, moderator: Dinesh Patel PhD.
3:00- 3:15 Closing Remarks Mr. Jeremy Neilson
PARKING: Parking for the Depot is across the street for $3 or in the gateway parking facilities (no validation available).
MR. MARK FOLEY, Managing Director for RWI Ventures
Mark joined RWI Ventures in 2004. Since joining, Mark has led RWI I’s investments in Chakshu, BaroSense and DermaCare, where he serves on the Board of all three companies. Prior to RWI Ventures, he spent 17 years in senior operating roles at both large and small start-up medical device companies, most recently founding and serving as CEO of cardiac device maker, Ventrica, which was acquired by Medtronic in 2004. Before Ventrica, Mark worked for leading device companies Perclose (acquired by Abbott), Guidant, DVI (acquired by Eli Lilly) and US Surgical Corporation (acquired by Tyco). Because of the breadth of his operating experience, Mark has an intimate understanding of all aspects of what it takes to make a start-up company successful, as well as an extensive rolodex and strong personal relationships with many key influencers in the Bay Area. Mark received his B.A. from the University of Notre Dame.
DR. RANDALL J. OLSON, M.D., Professor and Chairman; Director, John A. Moran Eye Center
One of the most respected and noted ophthalmologists in the country, Dr. Olson's practice is focused on all areas of cornea and external disease, as well as other anterior segment disorders. He has a special interest in intraocular lens related complications. Medical School: University of Utah School of Medicine - Salt Lake City, UT, Residency: Jules Stein Eye Institute - Los Angeles, CA, Fellowship: University of Florida and Louisiana State University Eye Center. Academic Appointments: Professor and Chair, Ophthalmology & Visual Sciences, University of Utah School of Medicine.
RICHARD J. LINDER, President and Chief Executive Officer, Coherex
Mr. Linder began his career in the medical device industry with Merit Medical Systems in Salt Lake City. In 1996, Mr. Linder co-founded Rubicon Medical, Inc. The company ﬁrst began as a contract manufacturer to companies such as Medtronic, Abbott Laboratories, CR Bard, and later began a worldwide business in equipment manufacturing, contract engineering, and design. In 2000, Rubicon licensed to Abbott Laboratories its Guardian balloon embolic protection system. The company also completed its public offering in 2000. About this time, Mr. Linder developed the fundamental and key design concepts for the Rubicon Filter, which propelled the business deeper into the embolic protection market. Under Mr. Linder’s leadership, Boston Scientific exercised an option to acquire Rubicon in 2005, which was the largest ﬁlter vascular protection transaction in history. Upon leaving Boston Scientific in 2006, Mr. Linder became President and CEO of Coherex Medical. Mr. Linder is a member of the Board of Directors of several companies, and is Chairman of the Board of Vital Access Corporation. He is also a member of the University of Utah Biomedical Industrial Advisory Board and the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).
DR. PETER FITZGERALD, M.D., Ph.D., Stanford Professor, Co-Founder of Stanford’s CRCI, and Co-founder of Latterell Venture Partners
Dr. Peter Fitzgerald is the Director of the Center for Research in Cardiovascular Interventions and the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University. He has a Ph.D. in Engineering and is an interventional cardiologist. Dr. Fitzgerald has served as the Principal Investigator for over 45 clinical trials involving intravascular ultrasound. Dr. Fitzgerald has a joint appointment in the School of Medicine and Engineering. His research is focused on signal and image processing of intravascular ultrasound for plaque characterization and advanced engineering developments in signal processing and catheter device development. In addition, Dr. Fitzgerald serves as a consultant and medical/advisory board member for several biomedical device and ehealth companies in and around the San Francisco Bay Area. Dr. Fitzgerald has been principle/founder of six medical device companies in the San Francisco Bay Area. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in Cardiology, Neurology and Orthopedics. Dr. Fitzgerald received his M.D. from Dartmouth Medical School and his Ph.D. in Biomechanical Engineering at Dartmouth College. Dr. Fitzgerald is also a co-founder of Latterell Venture Partners, formed in 2001 to invest exclusively in early stage healthcare companies, including biotechnology, pharmaceutical, research instrument, biomaterial, medical device and diagnostic ventures. Peter contributes clinical and engineering skills, along with 20 years of medical device startup experience, to LVP while maintaining his full duties as an Associate Professor of Medicine at Stanford.
DR. DINESH PATEL, Founding Managing Director, vSpring Capital
Dr. Patel is a founding managing director of vSpring Capital. From 1999 to 2004 he was the Founder, Chairman, President & CEO of Ashni Naturaceuticals, Inc., a company that specializes in the research, development and marketing of clinically tested and patent-protected naturaceutical products. He currently holds 15 US Patents and Foreign Counterparts. Prior to vSpring, Dr. Patel was an active angel investor in over 20 biotech and technology companies. In 1999, Dr. Patel co-founded and was the Chairman of Salus Therapeutics, Inc., a biotechnology company focused on the research and development of nucleic acid-based therapeutics, including antisense and gene therapy drugs. From 1985 – 1999 Dr. Patel served as Co-Founder, Chairman of The Board of Directors and President & CEO of TheraTech, Inc., a biotechnology company which he took public and eventually sold for $350 million to Watson Pharmaceuticals.
JEREMY NEILSON, Managing Director, Utah Fund of Funds
Mr. Neilson is the Managing Director of the Utah Fund of Funds which is a State of Utah economic development program investing $300 Million in local, regional and national venture capital and private equity funds that will focus investment efforts on evaluating Utah investments. Prior to the Utah Fund of Funds, Mr. Neilson was an associate with the University Venture Fund, a student run venture capital firm. Mr. Neilson holds a Bachelor’s degree in Business Management from Brigham Young University, a Masters in Business Administration from the University of Utah’s David Eccles School of Business and a Juris Doctor from Wake Forest University School of Law.
Mr. Kelly Christian is the Director of Product Development at Bard Access Systems. He obtained a Bachelors of Science in Physics from the University of Utah in 1988 and a Masters of Science in Biomedical Engineering from the University of Kentucky in 1990. Mr. Kelly Christian holds fourteen medical device patents. He worked as the Senior Biomedical Engineer at Bard Access Systems from 1990 to1996, the Director, Research and Development, Ballard Medical from 1996 to 2005 and was then hired as the Director, Product Development, Bard Access Systems in 2005. He was the Former Chair and is now a current member of the University of Utah Biomedical Engineering Industrial Advisory Board.